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The vasodilator-stimulated phosphoprotein (VASP) is a
member of the Ena/VASP-family, regulating actin and
cytoskeleton dynamics. Therefore, VASP is an important
mediator in processes such as cell-cell adhesion, aggrega-
tion, and cellular motility in platelet, fibroblasts, and
endothelial cells. The adaptor protein is located at the
intersection of two major cyclic nucleotide-dependent sig-
naling pathways, being a substrate of both cAMP- and
cGMP-dependent kinase. In vitro it is well established that
VASP is predominantly phosphorylated at Ser157 and
Thr278 residues by cAMP- and at Ser239 by cGMP-
dependent kinase, respectively. In contrast, the detailed
cellular functions of distinct VASP phosphorylation(s) in
vivo and kinases involved are controversial and are still a
matter of debate.
In order to analyze the specific cellular role of different
VASP phosphorylation patterns in living cells, we have
generated a set of 20 VASP mutants. In these constructs,
the phosphorylation sites Ser157, Ser239, and Thr278
were systematically exchanged to alanin and/or acidic
amino acids, respectively, to mimic permanent non-phos-
phorylated or phosphorylated states. Using these
mutants, we investigated subcellular localization in
endothelial cells and effects of single, double or triple
phosphorylated VASP on actin dynamics.
To specify the subcellular localization of the VASP
mutants in the absence of endogenous VASP, we immor-
talized microvascular endothelial cells from VASP-defi-
cient mice. Confocal laser scanning microscopy revealed
that VASP mutants bearing acidic residues at position 157
localized to the cell membrane. Importantly, Ser157-
phosphorylated endogenous VASP, probed by a phospho-
specific antibody, was found in the same cellular compart-
ment. In contrast, the membrane localization of overex-
pressed mutants in VASP-/- cells was independent of the
phosphorylation state at Ser239 and/or Thr278. In line
with these results, neither Ser239 nor Thr278 phosphor-
ylation did alter the distribution of endogenous VASP.
The effect of differential VASP phosphorylations on actin
dynamics was scrutinized using a serum response factor-
based reporter assay and FACS analysis of VASP-overex-
pressing cells. Phosphorylation at Ser239 and/or Thr278
increased the cellular amount of G-actin concomitant
with an inhibition of F-actin fiber formation. On the other
hand phoshorylations at Ser157 did not affect actin
dynamics, indicating that merely phosphorylations at
Ser239 and Thr278 but not Ser157, are important for
actin polymerization.
Taken together, these results suggest that distinct VASP-
phosphorylations have the potency to modulate the sub-
cellular localization of the protein and the actin turnover
in vivo, thereby linking cyclic nucleotide-dependent sign-
aling pathways to the cytoskeleton.
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